Karen Aiach-Pignet, CEO at Genespire, commented: “I strongly believe in a better world for patients with metabolic diseases. Leading Genespire, with the aim to develop and deliver safe and ...

Milan, Italy, 12 September 2024 – Genespire, a biotechnology company developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases, today announces the appointment of ...

After 25 years at Johnson & Johnson and 30 in the industry, Lucinda Warren is moving on to new pastures at Cue Biopharma as ...

Manoir Voltaire is co-listed by Rick Moeser of Douglas Elliman Real Estate, Xavier Pignet of Barnes Saint-Barth, and Kevin Barrallon of SBRE.